Determination of the residual ethanol in hydroalcoholic sealed hard gelatin capsules by static headspace gas chromatography with immiscible binary solvents.

Static headspace gas chromatography (HS-GC) with immiscible binary solvents is described to quantitatively determine the residual ethanol used to seal the hard gelatin capsules by liquid encapsulated and microspray sealing (LEMS; cfs 1200, Greenwood, SC, USA). The effects of decane, dodecane, heptane, 0.1M HCl, N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidinone and dimethyl sulfoxide on the method sensitivity are compared. It is observed that the ethanol headspace concentrations can be increased by fourfolds when aliphatic hydrocarbon solvents are added into the aqueous sample solutions in a HS vial. In addition, a mathematic model based on the concentration equilibriums of liquid-liquid and liquid-gas phases is derived to quantitatively describe the ethanol headspace concentrations versus the volumes of the aliphatic hydrocarbon solvents. The proposed model fits well to the experimental data. The impacts of the oven temperatures and vial equilibration times on the ethanol headspace concentrations are also investigated. Furthermore, the potential interferences of the capsule placebo and hard gelatin capsule shells on the selectivity and quantitation of the method are discussed. The linearity is validated from 5 microg/mL to 500 microg/mL. The limit of quantitation is 5 microg/mL. The accuracy is determined to be 100.8+/-6%. Finally, this method is successfully used to determine the residual ethanol in the sealed capsules of 5mg and 10mg developmental Drug A, and 100mg and 200mg developmental Drug B.

Simultaneous determination of cations, zwitterions and neutral compounds using mixed-mode reversed-phase and cation-exchange high-performance liquid chromatography.

A novel mixed-mode reversed-phase and cation-exchange high-performance liquid chromatography (HPLC) method is described to simultaneously determine four related impurities of cations, zwitterions and neutral compounds in developmental Drug A. The commercial column is Primesep 200 containing hydrophobic alkyl chains with embedded acidic groups in H(+) form on a silica support. The mobile phase variables of acid additives, contents of acetonitrile and concentrations of potassium chloride have been thoroughly investigated to optimize the separation. The retention factors as a function of the concentrations of potassium chloride and the percentages of acetonitrile in the mobile phases are investigated to get an insight into the retention and separation mechanisms of each related impurity and Drug A. Furthermore, the elution orders of the related impurities and Drug A in an ion-pair chromatography (IPC) are compared to those in the mixed-mode HPLC to further understand the chromatographic retention behaviors of each related impurity and Drug A. The study found that the positively charged Degradant 1, Degradant 2 and Drug A were retained by both ion-exchange and reversed-phase partitioning mechanisms. RI2, a small ionic compound, was primarily retained by ion-exchange. RI4, a neutral compound, was retained through reversed-phase partitioning without ion-exchange. Moreover, the method performance characteristics of selectivity, sensitivity and accuracy have been demonstrated to be suitable to determine the related impurities in the capsules of Drug A.